World Leprosy Day 2026: Make Dignity Part of Every Care Path

Dignity-first care network connecting accurate information, early recognition, treatment access, continuity, and participation for World Leprosy Day 2026.

The 2026 leadership signal

A curable disease still carries preventable barriers.

The World Health Organization observes World Leprosy Day on the last Sunday of January. In 2026, the date is January 25. WHO uses the day to celebrate people who have experienced leprosy, increase understanding of the disease, and call for an end to stigma and discrimination.

Leprosy, also known as Hansen disease, is a chronic infectious disease. WHO states that it is curable with multidrug therapy, does not spread through casual contact, and can cause progressive disability if left untreated. Stigma can discourage people from seeking diagnosis and treatment, making respectful communication an operational concern as well as a human-rights commitment.

Executive priority: build a care environment where accurate information replaces fear, concerns receive a timely clinical route, confidentiality is protected, and people affected by leprosy participate in decisions that concern them. In low-incidence settings, preparedness includes retaining a clear referral pathway even when cases are uncommon.

Reported in 2024172,717

cases were reported by 133 countries, according to the WHO Goodwill Ambassador’s 2026 message. Source

Children under 155.4%

of the cases reported in that 2024 total were children under age 15, a signal of ongoing transmission. Source

Transmission factNot casual contact

WHO states that leprosy does not spread by shaking hands, hugging, sharing meals, or sitting next to someone. Source

Accuracy note: the WHO event page correctly identifies January 25 in its heading and body. A later line on that page says January 26, which conflicts with the calendar and with January 25, 2026 being the last Sunday of the month. This brief follows WHO’s dated event record and 2026 Goodwill Ambassador message: January 25, 2026.

System route

Design one dignity-first route from concern to support.

The pathway should be easy for front-line teams to find and flexible enough to fit local epidemiology, public-health responsibilities, referral networks, and the preferences of the person seeking care.

Listen

Receive the concern without blame, jokes, alarmist language, or assumptions.

Inform

Use accurate, plain-language information and correct myths about casual contact.

Evaluate

Connect the person with an appropriately qualified clinical pathway for assessment.

Coordinate

Align treatment access, public-health responsibilities, and needed specialty support.

Sustain

Support treatment completion, complications, disability needs, well-being, and inclusion.

Command principle: respect is not a communication add-on. It is part of access, safety, continuity, and trust at every step.

Operating dashboard

Monitor whether people can reach informed, respectful care.

In settings with few cases, small numbers require careful interpretation and strong privacy controls. Review pathway readiness and individual barriers without publishing identifiable information.

Instrument 01

Information quality

Do public and internal materials use current facts and person-respecting language?

MeasureMaterials audited, corrected, and dated against current authoritative guidance

Instrument 02

Route readiness

Can front-line teams identify the clinical and public-health route without delay?

MeasureScenario tests that reach the correct referral and escalation contacts

Instrument 03

Connection

Does a concern move to an accepted evaluation rather than end with a phone number?

MeasureReferrals accepted, completed, or rerouted with a named owner

Instrument 04

Dignity and continuity

Are privacy, respectful treatment, follow-up, and support needs addressed across the route?

MeasureConcerns reviewed and follow-up actions completed with protected reporting

Care handoff

Transfer trust with the clinical information.

A coordinated handoff protects confidentiality and ends with an informed person, an accepting service, a named owner, and a clear next step.

Explain the reason for the connection

Use neutral, factual language and check what the person understands, needs, and prefers.

Protect privacy

Share information through approved channels and only as permitted by law, policy, and the circumstances of care.

Confirm the receiving route

Identify the appropriate clinical service and public-health contact, then verify who accepts the next action.

Close the loop

Track whether the connection occurred and address treatment, complication, disability, well-being, or social-support needs that emerge.

Executive scorecard

Measure preparedness, access, continuity, and dignity.

The WHO Global Leprosy Strategy pairs prevention and care with disability prevention, action on stigma, and respect for human rights. The scorecard should do the same.

Operational measures for a dignity-first leprosy pathway
Domain	Measure	Executive question
Knowledge	Percentage of audited materials and scripts aligned with current authoritative guidance	Are we reducing myths rather than repeating them?
Preparedness	Referral directory, public-health contacts, escalation owner, and pathway test current within the review cycle	Can an uncommon concern still reach the right expertise?
Connection	Evaluation referrals accepted, completed, or safely rerouted, with exceptions reviewed	Does responsibility survive the transition?
Continuity	Documented follow-up for treatment access and identified clinical or support needs	Can people remain connected over the full care path?
Dignity	Privacy or discrimination concerns reviewed and corrective actions completed	Where is the system creating avoidable harm or exclusion?
Participation	People affected by leprosy or representative organizations included in relevant education and pathway review	Are decisions informed by lived experience?

90-day activation plan

Turn one observance into a more trustworthy route.

Choose improvements that fit the organization’s incidence, role, and community. A low-volume pathway still deserves accurate information, an identified destination, and accountable ownership.

Days 1–30 · Listen

Audit the current experience

Name an executive sponsor and pathway owner.
Review language, images, forms, isolation cues, and education for accuracy and respect.
Map clinical, specialty, public-health, and support contacts.
Invite input from people affected by leprosy or representative organizations where feasible.

Days 31–60 · Align

Build the care route

Correct myths in public and internal materials.
Define referral acceptance, privacy, escalation, and loop-closure expectations.
Identify treatment, disability, rehabilitation, well-being, and social-support resources.
Train relevant teams using role-specific, non-stigmatizing scenarios.

Days 61–90 · Verify

Test and improve

Run the route-readiness scenario from more than one entry point.
Correct one failed connection or information gap.
Launch the four operating-dashboard instruments.
Set a recurring review appropriate to local risk and volume.

Make respect visible in the operating system.

World Leprosy Day asks healthcare leaders to confront two realities at once: leprosy is curable, and stigma can still disrupt education, access, treatment, work, family life, and belonging. Leaders can respond with accurate information, reliable pathways, protected dignity, and meaningful participation by people affected by leprosy.

2026 themeLeprosy is curable, the real challenge is stigma.

Authoritative resources

Reviewed August 2026. Date, theme, clinical facts, and global figures are attributed to the cited WHO sources. Numbers describe global reporting and should not be interpreted as local prevalence. This executive brief supports organizational planning and education. It does not replace individualized clinical assessment, public-health guidance, legal review, infection-prevention expertise, or applicable policy.